Researchers have developed the technology for a catheter-based device that would provide forward-looking, real-time, 3-D imaging from inside the heart, coronary arteries and peripheral blood vessels. With its volumetric imaging, the new device could better guide surgeons working in the heart, and potentially allow more of patients’ clogged arteries to be cleared without major surgery.
A new bioprinting method developed at the Wyss Institute for Biologically Inspired Engineering at Harvard Univ. creates intricately patterned 3-D tissue constructs with multiple types of cells and tiny blood vessels. The work represents a major step toward a longstanding goal of tissue engineers: creating human tissue constructs realistic enough to test drug safety and effectiveness.
Purdue Univ. researchers have developed a laser sensor that can identify Salmonella bacteria grown from food samples about three times faster than conventional detection methods. Known as BARDOT, the machine scans bacteria colonies and generates a distinct black and white "fingerprint" by which they can be identified. BARDOT takes less than 24 hrs to pinpoint Salmonella.
For four decades, polychlorinated biphenyls (PCBs) and heavy metals from nearby manufacturing plants flowed into New Bedford Harbor, creating one of the EPA’s largest Superfund cleanup sites. It’s also the site of an evolutionary puzzle: small Atlantic killifish are not only tolerating the toxic conditions in the harbor, they seem to be thriving there. In a new paper, researchers may have an explanation for their genetic resistance to PCBs.
To improve their chances of success, in vitro fertilization clinics need to assess the viability of the sperm they use. Now doctors may soon have a new technique to help them sort the good sperm cells from the less viable ones: a tracking system, developed by a team of researchers from four European institutions, that takes 3-D movies of living sperm.
Researchers have introduced a unique microrobotic technique to assemble the components of complex materials, the foundation of tissue engineering and 3-D printing. Tissue engineering and 3-D printing have become vitally important to the future of medicine for many reasons. The shortage of available organs for transplantation, for example, leaves many patients on waiting lists for life-saving treatment.
Plant growth is orchestrated by a spectrum of signals from hormones within a plant. A major group of plant hormones called cytokinins originate in the roots of plants, and their journey to growth areas on the stem and in leaves stimulates plant development. Though these phytohormones have been identified in the past, the molecular mechanism responsible for their transportation within plants was previously poorly understood. Until now.
Shape is thought to play an important role in the effectiveness of cells grown to repair or replace damaged tissue in the body. To help design new structures that enable cells to "shape up," researchers at NIST have come up with a way to measure, and more importantly, classify, the shapes cells tend to take in different environments.
For more than two years, researchers have been investigating melanopsin, a retina pigment capable of sensing light changes in the environment, informing the nervous system and synchronizing it with the day/night rhythm. They have found that this pigment is potentially more sensitive to light than its more famous counterpart rhodopsin, the pigment that allows night vision.
A team of physicists have used statistical mechanics and mathematical modeling to shed light on something known as epigenetic memory, which allows an organism to create a biological memory of some variable condition, such as quality of nutrition or temperature. The model highlights the "engineering" challenge a cell must constantly face during molecular recognition.
A one-letter change in the human genetic code can sometimes mean the difference between health and a serious disease. But replicating these tiny changes in human stem cells has proven challenging. Scientists at the Gladstone Institutes have found a way to efficiently edit the human genome one letter at a time, not only boosting researchers' ability to model human disease, but also paving the way for new therapies.
In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute have developed a potentially general approach to design drugs from genome sequence. As a proof of principle, they identified a highly potent compound that causes cancer cells to attack themselves and die.
Optogenetics allows scientists to control neurons’ electrical activity with light by engineering them to express light-sensitive proteins, called opsins. Most opsins respond to light in the blue-green range. Now, a team has discovered an opsin that is sensitive to red light, which allows researchers to independently control the activity of two populations of neurons at once, enabling much more complex studies of brain function.
In an editorial cartoon that appeared in a recent issue of The Journal of Clinical Investigation, a surgeon wields a scalpel over his patient. The caption reads: “Just a little nip here and there. We don’t want it to look like it’s had any work done.” The catch? The patient is a western blot, and the doctor is presumably making his patient look presentable for publication in a peer-reviewed journal.
As interest and investment in biopharmaceuticals grows, the pressure to innovate and rapidly deliver new therapies increases. While many avenues may be pursued, the high cost of developing biological molecules increases the need to advance only those therapies with the greatest likelihood of becoming manufacturable, efficacious, safe and profitable products.
The Salk Institute for Biological Studies will join Stanford Univ. in leading a new Center of Excellence in Stem Cell Genomics, created through a $40 million award by California's stem cell agency. The center will bring together experts and investigators from seven major California institutions to focus on bridging the fields of genomics with cutting-edge stem cell research and ultimately find new therapies.
Nearly 70% of patients with advanced breast cancer experience skeletal metastasis, in which cancer cells migrate from a primary tumor into bone. While scientists are attempting to better understand metastasis in general, not much is known about how and why certain cancers spread to specific organs. Now researchers have developed a 3-D microfluidic platform that mimics the spread of breast cancer cells into a bone-like environment.
A Texas bioengineer has received a four-year, $1.4 million National Institutes of Health grant to create a nanoparticle system to shore up arterial walls following angioplasty and stenting procedures to treat coronary arterial disease. Kytai Nguyen discovered a way to use nanoparticles to help the arteries heal themselves more effectively.
Our cells produce thousands of proteins, but more than one-third of these proteins can fulfill their function only after migrating to the outside of the cell. While it is known that protein migration occurs with the help of various “nanomotors” that push proteins out of the cell, little is known about their precise mechanical functioning. New research reveals the inner workings of one such nanomotor, called SecA, with new clarity.
In a Centers for Disease Control and Prevention (CDC) building on the outskirts of Atlanta, large metal vats are filled with a frozen array of specimens such as blood and DNA, many of them irreplaceable. Battelle has been awarded a five-year, $12.6 million contract to help manage this important biological repository, which contains 12 million biological samples.
In the early 1990s, MIT researcher Shuguang Zhang, then an MIT postdoctoral researcher, stumbled upon peptides that could self-assemble into nanostructures, creating 3-D environments for cell culturing. It was, at the time, a breakthrough discovery. But it wouldn’t be until a decade later, in a last-ditch effort to bring this discovery to the public, that these peptides would find commercial application through 3-D Matrix.
Researchers at NIST and in Lithuania have used a NIST-developed laboratory model of a simplified cell membrane to accurately detect and measure a protein associated with a serious gynecological disease, bacterial vaginosis (BV), at extraordinarily low concentrations. The work illustrates how the artificial membrane could be used to improve disease diagnosis.
Univ. of Oregon biologists say they have opened the window on the natural process of bone regeneration in zebra fish, and that the insights they gained could be used to advance therapies for bone fractures and disease. Their work shows that two molecular pathways work in concert to allow adult zebra fish to perfectly replace bones lost upon fin amputation.
Drugmaker Merck & Co. is joining two dozen other pharmaceutical companies and contract laboratories in committing to not use chimpanzees for research. The growing trend could mean roughly 1,000 chimps in the U.S. used for research or warehoused for many years in laboratory cages could be "retired" to sanctuaries by around 2020.
Continuous miniaturization in microelectronics is nearing physical limits, so researchers are seeking new methods for device fabrication. One promising candidate is a DNA origami technique in which individual strands of the biomolecule self-assemble into arbitrarily-shaped nanostructures. A new simpler strategy combines DNA origami with self-organized pattern formation to do away with elaborate procedures for positioning DNA structures.